Gilead Sciences (GILD) Other financing activities (2009 - 2026)
Gilead Sciences posted quarterly Other financing activities of -$179.0 million for Q1 2026, down 1.7% year-on-year from -$182.1 million in Q1 2025, and down 184.13% on a QoQ basis from -$63.0 million in Q4 2025.
Gilead Sciences (GILD) has 18 years of Other financing activities data on file, last reported at -$179.0 million in Q1 2026.
- For the quarter ending Q1 2026, Other financing activities fell 1.7% year-over-year to -$179.0 million; the trailing twelve-month figure through Mar 2026 stood at -$443.0 million (down 29.91% YoY), and the FY2025 full-year result was -$440.0 million, down 56.58% from the prior year.
- Other financing activities for Q1 2026 stood at -$179.0 million, down from -$63.0 million in the prior quarter.
- Across five years, Other financing activities topped out at -$14.0 million in Q2 2022 and bottomed at -$179.0 million in Q1 2026.
- The 5-year median for Other financing activities is -$64.0 million (2025), against an average of -$79.5 million.
- The widest annual swing landed in 2022, when Other financing activities sank 133.33%; it then advanced 14.07% in 2024.
- A 5-year view of Other financing activities shows it stood at -$23.0 million in 2022, then sank by 47.83% to -$34.0 million in 2023, then sank by 38.24% to -$47.0 million in 2024, then plunged by 34.04% to -$63.0 million in 2025, then slumped by 184.13% to -$179.0 million in 2026.
- The last three Other financing activities figures came in at -$179.0 million (Q1 2026), -$63.0 million (Q4 2025), and -$137.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -179.00 Mn |
| Mar 31, 2026 | -179.00 Mn |
| Dec 31, 2025 | -63.00 Mn |
| Dec 31, 2025 | -63.00 Mn |
| Sep 30, 2025 | -137.00 Mn |
| Sep 30, 2025 | -137.00 Mn |
| Jun 30, 2025 | -64.00 Mn |
| Jun 30, 2025 | -64.00 Mn |
| Mar 31, 2025 | -176.00 Mn |
| Mar 31, 2025 | -176.00 Mn |
| Dec 31, 2024 | -47.00 Mn |
| Dec 31, 2024 | -47.00 Mn |
| Sep 30, 2024 | -82.00 Mn |
| Sep 30, 2024 | -82.00 Mn |
| Jun 30, 2024 | -36.00 Mn |
| Jun 30, 2024 | -36.00 Mn |
| Mar 31, 2024 | -116.00 Mn |
| Mar 31, 2024 | -116.00 Mn |
| Dec 31, 2023 | -34.00 Mn |
| Dec 31, 2023 | -34.00 Mn |
| Sep 30, 2023 | -78.00 Mn |
| Sep 30, 2023 | -78.00 Mn |
| Jun 30, 2023 | -32.00 Mn |
| Jun 30, 2023 | -32.00 Mn |
| Mar 31, 2023 | -135.00 Mn |
| Mar 31, 2023 | -135.00 Mn |
| Dec 31, 2022 | -23.00 Mn |
| Dec 31, 2022 | -23.00 Mn |
| Sep 30, 2022 | -45.00 Mn |
| Sep 30, 2022 | -45.00 Mn |
| Jun 30, 2022 | -14.00 Mn |
| Jun 30, 2022 | -14.00 Mn |
| Mar 31, 2022 | -91.00 Mn |
| Mar 31, 2022 | -91.00 Mn |
| Dec 31, 2021 | -11.00 Mn |
| Dec 31, 2021 | -11.00 Mn |
| Sep 30, 2021 | -39.00 Mn |
| Sep 30, 2021 | -39.00 Mn |
| Jun 30, 2021 | -6.00 Mn |
| Jun 30, 2021 | -6.00 Mn |
| Mar 31, 2021 | -89.00 Mn |
| Mar 31, 2021 | -89.00 Mn |
| Dec 31, 2020 | -14.00 Mn |
| Dec 31, 2020 | -14.00 Mn |
| Sep 30, 2020 | -39.00 Mn |
| Sep 30, 2020 | -39.00 Mn |
| Jun 30, 2020 | 1.00 Mn |
| Jun 30, 2020 | 1.00 Mn |
| Mar 31, 2020 | -86.00 Mn |
| Mar 31, 2020 | -86.00 Mn |
| Dec 31, 2019 | -17.00 Mn |
| Dec 31, 2019 | -17.00 Mn |
| Sep 30, 2019 | -30.00 Mn |
| Sep 30, 2019 | -30.00 Mn |
| Jun 30, 2019 | -7.00 Mn |
| Jun 30, 2019 | -7.00 Mn |
| Mar 31, 2019 | -68.00 Mn |
| Mar 31, 2019 | -68.00 Mn |
| Dec 31, 2018 | -22.00 Mn |
| Dec 31, 2018 | -22.00 Mn |
| Sep 30, 2018 | -40.00 Mn |
| Sep 30, 2018 | -40.00 Mn |
| Jun 30, 2018 | -10.00 Mn |
| Jun 30, 2018 | -10.00 Mn |
| Mar 31, 2018 | -414.00 Mn |
| Mar 31, 2018 | -414.00 Mn |
| Dec 31, 2017 | -189.00 Mn |
| Dec 31, 2017 | -189.00 Mn |
| Sep 30, 2017 | -20.00 Mn |
| Sep 30, 2017 | -20.00 Mn |
| Jun 30, 2017 | -63.00 Mn |
| Jun 30, 2017 | -63.00 Mn |
| Mar 31, 2017 | -58.00 Mn |
| Mar 31, 2017 | -58.00 Mn |
| Dec 31, 2016 | -27.00 Mn |
| Dec 31, 2016 | -27.00 Mn |
| Sep 30, 2016 | -110.00 Mn |
| Sep 30, 2016 | -110.00 Mn |
| Jun 30, 2016 | -52.00 Mn |
| Jun 30, 2016 | -52.00 Mn |
| Mar 31, 2016 | -87.00 Mn |
| Mar 31, 2016 | -87.00 Mn |
| Dec 31, 2015 | -649.00 Mn |
| Dec 31, 2015 | -649.00 Mn |
| Sep 30, 2015 | 172.00 Mn |
| Sep 30, 2015 | 172.00 Mn |
| Jun 30, 2015 | 306.00 Mn |
| Jun 30, 2015 | 306.00 Mn |
| Mar 31, 2015 | 20.00 Mn |
| Mar 31, 2015 | 20.00 Mn |
| Dec 31, 2014 | 96.00 Mn |
| Dec 31, 2014 | 96.00 Mn |
| Sep 30, 2014 | -275.00 Mn |
| Sep 30, 2014 | -275.00 Mn |
| Jun 30, 2014 | 57.00 Mn |
| Jun 30, 2014 | 57.00 Mn |
| Mar 31, 2014 | 157.00 Mn |
| Mar 31, 2014 | 157.00 Mn |
| Dec 31, 2013 | 71.41 Mn |
| Dec 31, 2013 | 71.41 Mn |
| Sep 30, 2013 | -8.57 Mn |
| Sep 30, 2013 | -8.57 Mn |
| Jun 30, 2013 | 48.41 Mn |
| Jun 30, 2013 | 48.41 Mn |
| Mar 31, 2013 | 40.75 Mn |
| Mar 31, 2013 | 40.75 Mn |
| Dec 31, 2012 | 81.59 Mn |
| Dec 31, 2012 | 81.59 Mn |
| Sep 30, 2012 | 69.72 Mn |
| Sep 30, 2012 | 69.72 Mn |
| Jun 30, 2012 | 36.29 Mn |
| Jun 30, 2012 | 36.29 Mn |
| Mar 31, 2012 | -73.60 Mn |
| Mar 31, 2012 | -73.60 Mn |
| Dec 31, 2011 | 171.32 Mn |
| Dec 31, 2011 | 171.32 Mn |
| Sep 30, 2011 | -150.77 Mn |
| Sep 30, 2011 | -150.77 Mn |
| Jun 30, 2011 | 6.04 Mn |
| Jun 30, 2011 | 6.04 Mn |
| Mar 31, 2011 | 14.26 Mn |
| Mar 31, 2011 | 14.26 Mn |
| Dec 31, 2010 | 61.58 Mn |
| Dec 31, 2010 | 61.58 Mn |
| Sep 30, 2010 | 9.25 Mn |
| Sep 30, 2010 | 9.25 Mn |
| Jun 30, 2010 | 10.87 Mn |
| Jun 30, 2010 | 10.87 Mn |
| Mar 31, 2010 | 49.82 Mn |
| Mar 31, 2010 | 49.82 Mn |
| Dec 31, 2009 | 29.10 Mn |
| Dec 31, 2009 | 29.10 Mn |
| Sep 30, 2009 | 123.37 Mn |
| Sep 30, 2009 | 123.37 Mn |
| Jun 30, 2009 | -84.80 Mn |
| Jun 30, 2009 | -84.80 Mn |
| Mar 31, 2009 | 20.69 Mn |
| Mar 31, 2009 | 20.69 Mn |